Summa Equity acquires Axion BioSystems
Summa Equity has acquired Axion BioSystems, a provider of MEA and impedance technology for single-cell analysis.
16 July 2021•3 mins read
Summa Equity has acquired Axion BioSystems, a provider of MEA and impedance technology for single-cell analysis.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
9 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
9 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
9 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
9 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
10 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
10 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
12 hours ago · 3 mins read
